Bio Green Energy Tech PCL Statistics

Total Valuation

BKK:BIOTEC has a market cap or net worth of THB 549.60 million. The enterprise value is 906.05 million.

Market Cap	549.60M
Enterprise Value	906.05M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

BKK:BIOTEC has 3.05 billion shares outstanding.

Current Share Class	3.05B
Shares Outstanding	3.05B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	45.68%
Owned by Institutions (%)	0.02%
Float	1.06B

Valuation Ratios

The trailing PE ratio is 19.25.

PE Ratio	19.25
Forward PE	n/a
PS Ratio	0.13
PB Ratio	0.50
P/TBV Ratio	1.25
P/FCF Ratio	3.16
P/OCF Ratio	2.86
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.74, with an EV/FCF ratio of 5.22.

EV / Earnings	31.73
EV / Sales	0.22
EV / EBITDA	6.74
EV / EBIT	33.49
EV / FCF	5.22

Financial Position

The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.41.

Current Ratio	0.57
Quick Ratio	0.32
Debt / Equity	0.41
Debt / EBITDA	3.36
Debt / FCF	2.59
Interest Coverage	0.72

Financial Efficiency

Return on equity (ROE) is 2.68% and return on invested capital (ROIC) is 4.14%.

Return on Equity (ROE)	2.68%
Return on Assets (ROA)	0.67%
Return on Invested Capital (ROIC)	4.14%
Return on Capital Employed (ROCE)	1.94%
Weighted Average Cost of Capital (WACC)	3.67%
Revenue Per Employee	20.94M
Profits Per Employee	142,086
Employee Count	201
Asset Turnover	1.69
Inventory Turnover	17.08

Taxes

In the past 12 months, BKK:BIOTEC has paid 12.75 million in taxes.

Income Tax	12.75M
Effective Tax Rate	30.30%

Stock Price Statistics

The stock price has decreased by -5.26% in the last 52 weeks. The beta is -0.41, so BKK:BIOTEC's price volatility has been lower than the market average.

Beta (5Y)	-0.41
52-Week Price Change	-5.26%
50-Day Moving Average	0.18
200-Day Moving Average	0.19
Relative Strength Index (RSI)	47.98
Average Volume (20 Days)	2,452,093

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BKK:BIOTEC had revenue of THB 4.21 billion and earned 28.56 million in profits. Earnings per share was 0.01.

Revenue	4.21B
Gross Profit	159.11M
Operating Income	26.77M
Pretax Income	42.07M
Net Income	28.56M
EBITDA	116.29M
EBIT	26.77M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 100.52 million in cash and 450.66 million in debt, giving a net cash position of -350.14 million or -0.11 per share.

Cash & Cash Equivalents	100.52M
Total Debt	450.66M
Net Cash	-350.14M
Net Cash Per Share	-0.11
Equity (Book Value)	1.10B
Book Value Per Share	0.36
Working Capital	-370.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 191.95 million and capital expenditures -18.26 million, giving a free cash flow of 173.69 million.

Operating Cash Flow	191.95M
Capital Expenditures	-18.26M
Free Cash Flow	173.69M
FCF Per Share	0.06

Full Cash Flow Statement

Margins

Gross margin is 3.78%, with operating and profit margins of 0.64% and 0.70%.

Gross Margin	3.78%
Operating Margin	0.64%
Pretax Margin	1.00%
Profit Margin	0.70%
EBITDA Margin	2.76%
EBIT Margin	0.64%
FCF Margin	4.13%

Dividends & Yields

BKK:BIOTEC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	5.20%
FCF Yield	31.60%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BKK:BIOTEC has an Altman Z-Score of 1.71 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.71
Piotroski F-Score	7